In Part 3 of our conversation with Dr. Matt Kaeberlein, we discuss some of our desires for the future of Prime Health. Why do we exist? What kind of patient care do we offer? And what should we expect for our health future?
Dr. Matt Kaeberlein is the Chief Executive Officer at Optispan, Inc., Affiliate Professor of Oral Health Sciences at the University of Washington, and Co-Director of the Dog Aging Project. Dr. Kaeberlein’s research interests are focused on understanding biological mechanisms of aging in order to facilitate translational interventions that promote healthspan and improve quality of life for people and companion animals.
In Part 3 of our conversation with Dr. Matt Kaeberlein, we discuss some of our desires for the future of Prime Health. Why do we exist? What kind of patient care do we offer? And what should we expect for our health future?
Dr. Matt Kaeberlein is the Chief Executive Officer at Optispan, Inc., Affiliate Professor of Oral Health Sciences at the University of Washington, and Co-Director of the Dog Aging Project. Dr. Kaeberlein’s research interests are focused on understanding biological mechanisms of aging in order to facilitate translational interventions that promote healthspan and improve quality of life for people and companion animals.